While some anti-diabetic drugs has been shown to have beneficial effects on markers of vascular inflammation [41] and PTX3 decreased after 24 weeks of administration of sitagliptin [42], the effects of anti-diabetic treatment on PTX3 in GDM would be of interest. Here, PTX3 is linked to gestational diabetes.